Literature DB >> 34321169

Oncogenic roles of lncRNA BLACAT1 and its related mechanisms in human cancers.

Wei Han1, Fan Yu2, Wei Guan3.   

Abstract

Long non-coding RNAs (lncRNAs) play indispensable roles in mediating regulation of epigenetics, and their dysregulation is strongly associated with the initiation and progression of human cancers. Recently, lncRNA bladder cancer-associated transcript 1 (BLACAT1) has been observed to exert oncogenic effects on cancers, including glioma, breast cancer, lung cancer, hepatocellular carcinoma, gastric cancer, colorectal cancer, ovarian cancer, cervical cancer and osteosarcoma. Additional mechanical analyses have uncovered that lncRNA BLACAT1 is positively correlated with tumor stage, lymph node metastasis and distant metastasis of primary tumors via involvement with various cellular activities, thus leading to poor overall survival and progression-free survival (PFS). In this review, we generalize the oncogenic roles of BLACAT1 in multiple human cancers through correlation with clinical implications and cellular activities. Moreover, we forecast its potential clinical application as a novel biomarker and a promising therapeutic target for cancers.
Copyright © 2020 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  BLACAT1; Biomarker; Human cancers; LncRNA; Therapeutic target

Year:  2020        PMID: 34321169     DOI: 10.1016/j.biopha.2020.110632

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  4 in total

1.  Genome-wide Exploration of a Pyroptosis-Related Long Non-Coding RNA Signature Associated With the Prognosis and Immune Response in Patients With Bladder Cancer.

Authors:  Xin Gao; Jianping Cai
Journal:  Front Genet       Date:  2022-04-27       Impact factor: 4.772

2.  Major Role for Cellular MicroRNAs, Long Noncoding RNAs (lncRNAs), and the Epstein-Barr Virus-Encoded BART lncRNA during Tumor Growth In Vivo.

Authors:  Rachel Hood Edwards; Nancy Raab-Traub
Journal:  mBio       Date:  2022-04-18       Impact factor: 7.786

3.  LncRNA SNHG6 knockdown inhibits cisplatin resistance and progression of gastric cancer through miR-1297/BCL-2 axis.

Authors:  Jiazhan Mei; Guiju Liu; Ruijun Li; Peng Xiao; Dan Yang; Hua Bai; Yibin Hao
Journal:  Biosci Rep       Date:  2021-12-22       Impact factor: 3.840

4.  Long Non-Coding RNAs Expression in Breast Cancer: CBR3-AS1 LncRNA as a Sensitive Biomarker.

Authors:  Safora Torkashvand; Ali Basi; Hossein Ajdarkosh; Nasser Rakhshani; Nahid Nafisi; Seyed Javad Mowla; Ayda Moghadas; Mahshid Mohammadipour; Mohammad Hadi Karbalaie Niya
Journal:  Asian Pac J Cancer Prev       Date:  2021-09-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.